Breaking News
7 minutes ago
Simantini Singh Deo
Polyrizon signs a CRO agreement to begin ISO 10993 GLP biocompatibility studies in Q2 2026, advancing its intranasal medical device platform toward first-in-human trials.
Simantini Singh Deo
Transpire Bio appoints Ewan Livesey as Head of Business Development to lead in-licensing, out-licensing, and co-development for its inhaled therapeutics pipeline.
Simantini Singh Deo
NovaBridge Biosciences gets positive U.S. Food and Drug Administration feedback on accelerated approval plans for givastomig in first-line gastroesophageal cancer.
Simantini Singh Deo
Dyadic Applied BioSolutions signs an OEM deal with Integrated Biotherapeutics to expand global distribution of recombinant proteins and support commercial growth.
Simantini Singh Deo